This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Aug;56(2):398-9.

doi: 10.1016/j.eururo.2009.05.039.

Re: Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastasis and improves survival: long-term follow-up of a randomized clinical trial

Eduardo Solsona¹

Affiliations

PMID: 19691137
DOI: 10.1016/j.eururo.2009.05.039

Comment

Re: Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastasis and improves survival: long-term follow-up of a randomized clinical trial

Eduardo Solsona. Eur Urol. 2009 Aug.

. 2009 Aug;56(2):398-9.

doi: 10.1016/j.eururo.2009.05.039.

Author

Eduardo Solsona¹

Affiliation

¹ Instituto Valenciano de Oncología, Valencia, Spain. solsona@pulso.com

PMID: 19691137
DOI: 10.1016/j.eururo.2009.05.039

No abstract available

PubMed Disclaimer

Comment on

Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial.
Thompson IM, Tangen CM, Paradelo J, Lucia MS, Miller G, Troyer D, Messing E, Forman J, Chin J, Swanson G, Canby-Hagino E, Crawford ED. Thompson IM, et al. J Urol. 2009 Mar;181(3):956-62. doi: 10.1016/j.juro.2008.11.032. Epub 2009 Jan 23. J Urol. 2009. PMID: 19167731 Free PMC article. Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science